Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
about
In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right PlatformMulticellular tumor spheroids for evaluation of cytotoxicity and tumor growth inhibitory effects of nanomedicines in vitro: a comparison of docetaxel-loaded block copolymer micelles and Taxotere®Development of nanoscale approaches for ovarian cancer therapeutics and diagnosticsMultifunctional polymeric micelles for delivery of drugs and siRNA.Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid TumorsDual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.Dendrimer-Functionalized Laponite Nanodisks as a Platform for Anticancer Drug Delivery.Bioengineered yeast-derived vacuoles with enhanced tissue-penetrating ability for targeted cancer therapyDual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammationNanopreparations to overcome multidrug resistance in cancer.Applications of micelle enhancement in luminescence-based analysis.Polymeric nano-micelles: versatile platform for targeted delivery in cancer.Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.Bioprinted 3D vascularized tissue model for drug toxicity analysis.Antibody-targeted biodegradable nanoparticles for cancer therapy.The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles.Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics.Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids.Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs.A robust and quantitative method for tracking liposome contents after intravenous administration.Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles.Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-Delivery Triggered by Dual Stimuli in Tumor TissueTumor Spheroids as an in vitro model for determining the therapeutic response to proton beam radiotherapy and thermally sensitive nanocarriers.Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG.Efficacy of DOPE/DC-cholesterol liposomes and GCPQ micelles as AZD6244 nanocarriers in a 3D colorectal cancer in vitro model.The Chemistry of Bioconjugation in Nanoparticles-Based Drug Delivery System
P2860
Q26767210-07AFF38C-DA79-4E67-ABAB-54350C98E277Q28486451-9E584CE0-91E4-4579-9B64-C83051D10098Q30421664-B48E280A-C61E-4B3F-A6D9-916DD14C506DQ30438973-C8893E7C-5AD0-49C6-B95D-8EDBCCF11CACQ34110128-B1F18EFF-015B-4D77-9E6E-BA5B7DAF2C7BQ34615075-486215B0-D959-4093-AA04-8EBC68E02B82Q35100982-1E5A9F7D-A6EC-41E1-9059-6379F0D12CB3Q35868868-DFE54D4F-32AC-412D-B35D-2700B922D241Q36010344-84A38273-FF10-4667-BB38-768584A2F68BQ36324230-BDD03F04-3277-423F-9F85-906873E20F5EQ36498417-01EC9883-7520-4764-8238-5B785A447B5BQ36542204-99BDD62C-4AAF-4764-957D-3409555731CDQ36721811-B16474FA-463D-4A40-88B6-29F34DDE023DQ38131264-5AC2405F-E210-4D0D-B974-8B593759D1CAQ38209830-7DA531F8-B2D4-4E4A-94E2-57A43EA6B567Q38270690-A37768A0-4EEE-473F-896D-90CC8C177DF7Q38495033-D96B72A4-1C9F-468D-BFD8-1AEE4B1FEEBCQ38635845-BAB1521D-A661-4C5C-B08B-2BAE60596345Q38665261-C7A92566-C619-4458-A5B9-D18743C4E5FEQ38746950-ABCC3A60-B374-4B1A-BCC6-68C233CBDB22Q38788181-4325BA2B-22FB-47A2-9585-68239DE4F2E4Q38802267-3B654280-DF9F-41C7-9880-8D165CDEDBC7Q38830237-C8DE769C-609F-4D1A-BB32-D6D4F50BB01AQ39024424-7AA3F484-8013-4F83-B9A7-953790E3BA3EQ39103231-854E270B-4A8B-4C3D-AE8C-A54D69FCBD1DQ40124132-7EB8B68D-FB7C-47C5-A0B6-803E0AAD2BC9Q41656018-21CDE5EA-39AC-4A66-9676-FFB7350F6FABQ41957693-842C1FA3-5A9F-4159-84D8-E95EE0E80A92Q42352599-151DD78E-E725-41F7-9D85-B55091539AF5Q42591859-50E57938-717B-4CC7-836C-6B22B6C4806EQ50428793-305110C5-E3F3-4385-91CD-85D50299D412Q52888231-253921A4-948D-4C5F-B37D-9427E0518992Q59101713-15A3FD3A-383C-45CA-8C6A-59EDDDEFA27A
P2860
Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Accumulation and toxicity of a ...... an cancer cell spheroid model.
@ast
Accumulation and toxicity of a ...... an cancer cell spheroid model.
@en
type
label
Accumulation and toxicity of a ...... an cancer cell spheroid model.
@ast
Accumulation and toxicity of a ...... an cancer cell spheroid model.
@en
prefLabel
Accumulation and toxicity of a ...... an cancer cell spheroid model.
@ast
Accumulation and toxicity of a ...... an cancer cell spheroid model.
@en
P2860
P921
P1476
Accumulation and toxicity of a ...... ian cancer cell spheroid model
@en
P2093
Federico Perche
Vladimir P Torchilin
P2860
P304
P356
10.1016/J.JCONREL.2012.09.003
P407
P577
2012-09-10T00:00:00Z